R W Light Selected Research

Talc

8/2003	Transforming growth factor-beta induces collagen synthesis without inducing IL-8 production in mesothelial cells.
11/2001	Talc should not be used for pleurodesis in patients with nonmalignant pleural effusions.
6/2001	Talc preparations used for pleurodesis vary markedly from one preparation to another.
5/2001	Experimental pleurodesis in rabbits induced by silver nitrate or talc: 1-year follow-up.
3/2001	Thoracoscopy talc poudrage : a 15-year experience.
3/2001	Transforming growth factor-beta2 induces pleurodesis significantly faster than talc.
1/2001	[The effects of intrapleural anti-TNFalpha antibody on chemical pleurodesis induced by talc slurry or doxycycline].
9/2000	Silver nitrate is superior to talc slurry in producing pleurodesis in rabbits.
7/2000	Management of pleural effusions.
7/2000	Diseases of the pleura: the use of talc for pleurodesis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R W Light Research Topics

Disease

21	Pleural Effusion (Pleural Effusions) 01/2017 - 01/2000
6	Inflammation (Inflammations) 08/2003 - 09/2000
6	Fibrosis (Cirrhosis) 08/2001 - 07/2000
5	Empyema 11/2009 - 01/2000
4	Heart Failure 08/2006 - 07/2000
4	Pneumothorax 03/2001 - 07/2000
3	Lung Neoplasms (Lung Cancer) 08/2006 - 01/2001
3	Pneumonia (Pneumonitis) 06/2001 - 07/2000
2	Malignant Pleural Effusion 02/2016 - 07/2000
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 07/2000 - 07/2000
1	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2017
1	Tuberous Sclerosis (Bourneville's Disease) 01/2017
1	Disease Progression 01/2017
1	Neurocutaneous Syndromes (Phakomatoses) 01/2017
1	Seizures (Absence Seizure) 01/2017
1	Lymphadenopathy 01/2017
1	Cysts 01/2017
1	Angiomyolipoma 01/2017
1	Hemorrhage 01/2017
1	Chylothorax 01/2017
1	Hyperplasia 01/2017
1	Angiofibroma 01/2017
1	Pleurisy (Pleuritis) 01/2007
1	Infections 11/2006
1	Pleural Empyema (Pyothorax) 05/2005
1	Tuberculosis (Tuberculoses) 02/2003
1	Embolism (Embolus) 07/2001
1	Ischemia 07/2001
1	Pulmonary Tuberculosis 03/2001
1	Adenocarcinoma 03/2001
1	Bronchogenic Carcinoma 03/2001
1	Small Cell Carcinoma 03/2001
1	Pancreatic Diseases (Pancreatic Disease) 01/2001
1	Rupture 01/2001
1	Pancreatitis 01/2001
1	Suppuration 07/2000
1	Dyspnea (Shortness of Breath) 07/2000
1	Neoplasm Metastasis (Metastasis) 07/2000
1	Pleural Tuberculosis 07/2000
1	Nephrosis 07/2000

Drug/Important Bio-Agent (IBA)

11	Talc FDA Link 08/2003 - 01/2000
4	Transforming Growth Factor beta2IBA 08/2003 - 03/2001
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 02/2016 - 07/2000
3	CollagenIBA 08/2003 - 03/2001
3	Adenosine DeaminaseIBA 02/2003 - 07/2000
3	CytokinesIBA 08/2001 - 03/2001
3	Proteins (Proteins, Gene)FDA Link 08/2001 - 07/2000
3	Transforming Growth Factor beta (TGF-beta)IBA 12/2000 - 07/2000
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2009 - 06/2000
2	Coloring Agents (Dyes)IBA 11/2006 - 07/2000
2	TurpentineIBA 05/2005 - 09/2004
2	Tetracycline (Achromycin)FDA LinkGeneric 08/2003 - 07/2000
2	Silver NitrateIBA 05/2001 - 09/2000
2	Glucose (Dextrose)FDA LinkGeneric 01/2001 - 07/2000
2	Doxycycline (Periostat)FDA LinkGeneric 01/2001 - 01/2000
1	Factor XIII (Coagulation Factor XIII)IBA 01/2017
1	Triglycerides (Triacylglycerol)IBA 01/2017
1	trans-sodium crocetinate (crocetin)IBA 01/2017
1	lipoarabinomannan (LAM)IBA 01/2017
1	Pharmaceutical PreparationsIBA 12/2011
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2007
1	Antinuclear AntibodiesIBA 01/2007
1	AutoantibodiesIBA 01/2007
1	fibrin fragment D (D-dimer)IBA 08/2006
1	MacrolidesIBA 05/2005
1	Clarithromycin (Biaxin)FDA LinkGeneric 05/2005
1	Levofloxacin (Levaquin)FDA Link 09/2004
1	Moxifloxacin (Avelox)FDA Link 09/2004
1	QuinolonesIBA 09/2004
1	Adenosine (Adenocard)FDA LinkGeneric 02/2003
1	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2001
1	SteroidsIBA 08/2001
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 07/2001
1	NeopterinIBA 03/2001
1	Amylases FDA Link 01/2001
1	Protein Isoforms (Isoforms)IBA 12/2000
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2000
1	SuspensionsIBA 07/2000
1	Interferon-gamma (Interferon, gamma)IBA 07/2000
1	Sclerosing Solutions (Sclerosing Agents)IBA 07/2000
1	Vancomycin FDA LinkGeneric 06/2000
1	Gentamicins (Gentamicin)FDA LinkGeneric 06/2000
1	Metronidazole (Metric)FDA LinkGeneric 06/2000
1	Clindamycin (Cleocin)FDA LinkGeneric 06/2000
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 06/2000
1	Penicillins (Penicillin)FDA Link 06/2000
1	FibrinIBA 01/2000
1	Streptodornase and StreptokinaseIBA 01/2000
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2000
1	Streptokinase FDA Link 01/2000

Therapy/Procedure

11	Pleurodesis 11/2001 - 07/2000
5	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 08/2006 - 09/2000
1	Nephrectomy 01/2017
1	Nutritional Support (Artificial Feeding) 11/2009
1	Thoracotomy 11/2009
1	Thoracostomy 11/2009
1	Intravenous Administration 05/2005
1	Therapeutics 07/2000
1	Radiotherapy 07/2000